Pharmaron Beijing Co Ltd
SZSE:300759
Pharmaron Beijing Co Ltd
SZSE:300759
Price:
29.54
CNY
-0.94%
Market Closed
Market Cap:
¥52.3B
Relative Value
The Relative Value of one
Pharmaron Beijing Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 29.54 CNY,
Pharmaron Beijing Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Pharmaron Beijing Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Pharmaron Beijing Co Ltd Competitors
Pharmaron Beijing Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
52.5B CNY | 3.9 | 34.7 | 28 | 28 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 368.3 | 4 361 | 1 382.7 | 2 954.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
194.7B USD | 4.4 | 29.2 | 20.3 | 27.3 | |
| US |
|
Danaher Corp
NYSE:DHR
|
147.8B USD | 6 | 40.9 | 22.7 | 34.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 14.4 | 49.6 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.5B CHF | 5.6 | 38.9 | 28.7 | 28.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280.9B CNY | 6.3 | 18.7 | 18.9 | 18.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
33.6B USD | 4.9 | 25.9 | 19 | 22.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28B USD | 7 | 32.3 | 23.8 | 26.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.8B USD | 1.8 | 21.2 | 11.8 | 17.7 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.2B HKD | 7.2 | 34.4 | 24.1 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
